72.19.Z - Scientific research and development activities
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
70.22.Z - Head office activities and management consultancy
71.12.Z - Engineering activities and related technical consultancy
71.20.A - Food quality testing and analysis
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
74.10.Z - Specialized design activities
2020 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,4 | -6,2 | -11,7 | -87,9 |
EBITDA | -1,4 | -6 | -12 | -99,2 |
Short time liabilities | 1,6 | 0,6 | 2,5 | 285,4 |
Equity capital | -1 | 6 | 10,5 | 75,9 |
Operating profit (EBIT) | -1,4 | -6,1 | -12,1 | -97,9 |
Assets | 3,1 | 10,6 | 17 | 60,8 |
Net profit (loss) | -1,4 | -6,2 | -11,7 | -87,9 |
Cash | 2,2 | 3,1 | 7,2 | 129,4 |
Net income from sale | 0 | 0 | 0 | -∞ |
Liabilities and provisions for liabilities | 4,1 | 4,6 | 6,5 | 41,2 |
Working assets | 2,4 | 4,2 | 15,6 | 269 |
Depreciation | 0,1 | 0,1 | 0,2 | 34,5 |
% | % | % | p.p. | |
Profitability of capital | 140,3 | -104,5 | -111,7 | -7,2 |
Equity capital to total assets | -33,3 | 56,4 | 61,7 | 5,3 |
Gross profit margin | -47 492 | |||
EBITDA Margin | -48 581,3 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 36 475 | -2 147 447 173 |
Current financial liquidity indicator | 0.610934853553772 | 0 | ||
Net dept to EBITDA | 0.8469622731208801 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane